Mercredi, 17 Octobre 2018
Dernières nouvelles
Principale » Walgreens Boots Alliance Inc (WBA) Holdings Trimmed by Sprucegrove Investment Management Ltd.

Walgreens Boots Alliance Inc (WBA) Holdings Trimmed by Sprucegrove Investment Management Ltd.

07 Décembre 2017

Andra AP fonden raised its stake in Walgreens Boots Alliance by 35.3% during the second quarter.

The stock of Walgreens Boots Alliance, Inc. Sure, the percentage is encouraging but better times are ahead as looking out over a next 5-year period, analysts expect the company to see its earnings go up by 15.4%, annually.

USA pharmacy giant Walgreens Boots Alliance (Walgreens) announced on Wednesday it would invest 2.767 billion RMB (around 416 million US dollars) in a top pharmacy chain in China, to boost its investment in the country. Institutional investors own 60.24% of the company's stock.

(NASDAQ:WBA) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. Sprucegrove Investment Management Ltd.'s holdings in Walgreens Boots Alliance were worth $7,862,000 as of its most recent filing with the Securities and Exchange Commission (SEC). The stock has a market cap of $87.99 billion, a PE ratio of 20.927 and a beta of 1.20. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. (NASDAQ:WBA) earnings have risen with a quarterly rate of 10.5% over the last 5 years. (NASDAQ:WBA) Earnings Growing Rapidly? The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm's revenue for the quarter was up 5.3% compared to the same quarter previous year.

The good news is there's still room for Walgreens Boots Alliance, Inc. The company was initiated on Friday, November 3 by Credit Suisse. Stock buyback programs are often a sign that the company's management believes its shares are undervalued.

Bombay High Court upholds RERA Act
As per the Act, developers, projects and agents had time till July 31 to compulsorily register their projects with the Authority. The court also struck down a provision that provided for appointment of bureaucrats as members of an appellate tribunal .

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. This represents a $1.60 annualized dividend and a yield of 2.25%. Stockholders of record on Monday, November 13th will be given a $0.40 dividend. Walgreens Boots Alliance's dividend payout ratio (DPR) is now 42.33%. The rating was maintained by Loop Capital with "Buy" on Thursday, October 26. Company trades at a P/E ratio of 18.58, and is less expensive than the average stock in the Drug Stores industry. Following the purchase, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The average 1-year price target for (WBA) reveals an average price target of $84.96 per share. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this purchase can be found here. That's a potential 21.06 gain from where (NASDAQ:WBA) has been trading recently. UBS reissued a "buy" rating and set a $96.00 target price (down previously from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. They set a "hold" rating and a $78.00 price objective on the stock. Raymond James Financial reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. Walgreens Boots Alliance now has a consensus rating of "Buy" and a consensus target price of $90.62. A ratio under 1 points out that the company's liabilities are higher than its assets and indicates that the company may be unable to pay off its obligations when they fall short. Barclays PLC set a $79.00 price objective on shares of Walgreens Boots Alliance and gave the company a "hold" rating in a research report on Saturday, April 1st. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company's stock. Finally, Walgreens Boots Alliance, Inc.'s return on investment stands at 11.90% when you divide the shareholder's return by the cost.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. SunTrust maintained Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company.

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. GuoDa operates and franchises 3,500 retail pharmacies across China.

Walgreens Boots Alliance Inc (WBA) Holdings Trimmed by Sprucegrove Investment Management Ltd.